Insulet Corp. (PODD) recently announced that its Omnipod 5 Automated Insulin Delivery (“AID”) system is now available in France with Dexcom’s (DXCM) G6 sensor integration. Additionally, the company made the full commercial launch of the system with G7 compatibility in the United States and rolled out the Omnipod 5 App through a limited market release for iPhone.These significant developments reflect Insulet’s efforts to make its ground-breaking diabetes technology available to more people globally.More on t ...